Immune senescence markers such as CD57 + CD8 + T cells correlate with poor prognosis, whereas PD1 + CD8 + T cells associate with better outcomes, highlighting the interplay between senescence and immune dysfunction [213, 214]. Here, CD8A is linked to immune system disorder.